← Eichor
Study identifier: NCT05504772 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Precision Medicine for Every Child With Cancer

Condition: Childhood Cancer · Childhood Solid Tumor · Childhood Brain Tumor  ·  Sponsor: Australian & New Zealand Children's Haematology/Oncology Group

PhaseN/A
Planned participants3500
Who can joinAll sexes, 0 Years to 25 Years
Healthy volunteersNo

About this study

To improve outcomes for childhood cancer patients through the implementation of precision medicine.

This description comes directly from the study's public registry record.

Talk to the study team

National Study Coordinator  ·  +61 2 9382 3102  ·  SCHN-ZERO2@health.nsw.gov.au

Always discuss trial participation with your own doctor first.

Locations (11)

Women's and Children's HospitalAdelaide, AustraliaRecruiting
Queensland Children's HospitalBrisbane, AustraliaRecruiting
Royal Hobart HospitalHobart, AustraliaRecruiting
Monash Children's HospitalMelbourne, AustraliaRecruiting
Royal Children's HospitalMelbourne, AustraliaRecruiting
John Hunter Children's HospitalNewcastle, AustraliaRecruiting
Perth Children's HospitalPerth, AustraliaRecruiting
Sydney Children's Hospital, RandwickSydney, AustraliaRecruiting
The Children's Hospital at WestmeadSydney, AustraliaRecruiting
Starship Children's HospitalAuckland, Grafton, New ZealandRecruiting
Christchurch HospitalChristchurch, New ZealandNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05504772